The life sciences industry has spent decades competing on innovation, efficacy, and access. Yet as products proliferate, information becomes ubiquitous, and AI reshapes engagement, organizations face a new question: When science is comparable, what drives confidence, trust, adoption, adherence, and loyalty? This session explores idea and provides practical approaches that experiences . . . the realities patients, clinicians, and care teams encounter across awareness, access, treatment, support, and follow-through . . . may be the most overlooked drivers of both human and business outcomes.
